Zelitrex /01269701/


Indications and Reactions:

Role Indications Reactions
Secondary
Diabetes Mellitus Non-insulin-dependent 50.0%
Type 2 Diabetes Mellitus 50.0%
Thrombocytopenia 100.0%
Concomitant
Multiple Myeloma 34.1%
Prophylaxis 23.4%
Plasma Cell Myeloma 8.0%
Mantle Cell Lymphoma 4.0%
Pain 3.9%
Hypertension 3.4%
Product Used For Unknown Indication 2.9%
Infection Prophylaxis 2.7%
Anaemia 2.4%
Constipation 2.2%
Back Pain 2.0%
Bone Pain 1.6%
Thrombosis Prophylaxis 1.5%
Depression 1.4%
Hypercholesterolaemia 1.2%
Prostatic Adenoma 1.2%
Antibiotic Prophylaxis 1.1%
Hyperuricaemia 1.1%
Pain Prophylaxis 1.0%
Diabetes Mellitus 0.9%
Lung Disorder 21.3%
Thrombocytopenia 14.7%
General Physical Health Deterioration 6.7%
Febrile Neutropenia 5.3%
Extrapyramidal Disorder 4.0%
Fall 4.0%
Performance Status Decreased 4.0%
Pyrexia 4.0%
Septic Shock 4.0%
Sigmoiditis 4.0%
Thrombosis 4.0%
Abdominal Distension 2.7%
Chest Pain 2.7%
Diarrhoea 2.7%
Hordeolum 2.7%
Inappropriate Antidiuretic Hormone Secretion 2.7%
Lymphoma Transformation 2.7%
Musculoskeletal Chest Pain 2.7%
Oesophagitis 2.7%
Palpitations 2.7%

Drug Data